VKTX Today - Jul 13: Dips Despite Buyout Buzz

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

VKTX Today - Jul 13: Dips Despite Buyout Buzz

無料で聴く

ポッドキャストの詳細を見る

Hey, what’s up? It’s Joey here, your friendly neighborhood investor. Today, we’re talking about Viking Therapeutics, or VKTX. It was a red day for them, down about 2.4%. Oof, yeah, that one stung a bit.

So, what happened? The stock got smoked today, dropping while the rest of the market seemed to be on a bit of a roll. It opened okay but just kinda slipped throughout the day. Volume was way lower than usual, which isn’t usually a good sign. People weren’t exactly rushing to buy in, that’s for sure.

Now, why did this happen? Well, there’s some chatter around VKTX being a potential buyout target, especially with big pharma looking for the next big winner in the GLP-1 space. CNBC even flagged it, which usually gets folks buzzing. But despite that news, the stock still took a dive. Maybe people were just cashing out after the hype, or there’s some uncertainty floating around—nobody really knows.

And speaking of uncertainty, there's been some bearish options activity popping up lately, especially with Eli Lilly. Some folks think that could spill over and impact VKTX too. So, while there’s interest in Viking, it seems like a lot of investors are playing it cautious right now.

On a brighter note, there’s buzz about the potential for Viking to hit $50 down the line. That could definitely get people excited if it starts gaining traction again. But for now, it’s a bit of a wait-and-see game.

Alright, that’s the scoop for today. Just keep in mind, I’m here to share info and have a good time talking stocks, not giving financial advice. Stay chill, and catch you next time!

まだレビューはありません